SCN8A DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY SYNDROME

Clinical trials for SCN8A DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY SYNDROME explained in plain language.

Never miss a new study

Get alerted when new SCN8A DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY SYNDROME trials appear

Sign up with your email to follow new studies for SCN8A DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New hope for controlling rare childhood epilepsy

Disease control Terminated

This study tested whether adding a new drug called NBI-921352 to a patient's current seizure medications could help reduce seizure frequency in children and young adults with a rare genetic epilepsy called SCN8A-DEE. It was a Phase 2 trial that compared the drug to a placebo (ina…

Matched conditions: SCN8A DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY SYNDROME

Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

SCN8A DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY SYNDROME

Get alerted when new SCN8A DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY SYNDROME trials appear

New hope for controlling rare childhood epilepsy